Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002314420 | SCV000847976 | benign | Inborn genetic diseases | 2017-12-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV000887290 | SCV001030840 | benign | not provided | 2024-01-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000887290 | SCV001862387 | benign | not provided | 2021-01-11 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002253585 | SCV002524714 | benign | ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000887290 | SCV004154703 | benign | not provided | 2023-01-01 | criteria provided, single submitter | clinical testing | ADNP: BP4, BS1, BS2 |
Prevention |
RCV003953269 | SCV004770408 | benign | ADNP-related disorder | 2021-06-15 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |